Publications by authors named "Tamara Loos"

Claim this Profile
I
Improved planning of leukapheresis endpoint with customized prediction algorithm: minimizing collection days, volume of blood processed, procedure time, and citrate toxicity.
Daniel L Leberfinger, Kira L Badman, Joseph M Roig, Tamara Loos

Transfusion· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences.
Olav Sundnes, Wojciech Pietka, Tamara Loos, Jon Sponheim, Andrew L Rankin

J Invest Dermatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.
Jürgen Pollheimer, Johanna Bodin, Olav Sundnes, Reidunn J Edelmann, Sigrid S Skånland, Tamara Loos

Arterioscler Thromb Vasc Biol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.
Jon Sponheim, Jürgen Pollheimer, Trine Olsen, Johanna Balogh, Clara Hammarström, Tamara Loos

Am J Pathol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity.
Anneleen Mortier, Tamara Loos, Mieke Gouwy, Isabelle Ronsse, Jo Van Damme

J Biol Chem· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transnational histories of sexualities in Asia.
Tamara Loos

Am Hist Rev· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation.
Tamara Loos, Ghislain Opdenakker, Jo Van Damme, Paul Proost

Haematologica· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chapter 1. Isolation, identification, and production of posttranslationally modified chemokines.
Tamara Loos, Anneleen Mortier, Paul Proost

Methods Enzymol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Sofie Struyf, Samuel Noppen, Tamara Loos, Anneleen Mortier, Mieke Gouwy

J Immunol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Tamara Loos, Anneleen Mortier, Mieke Gouwy, Isabelle Ronsse, Willy Put

Blood· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.
Paul Proost, Tamara Loos, Anneleen Mortier, Evemie Schutyser, Mieke Gouwy

J Exp Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
Paul Proost, Anneleen Mortier, Tamara Loos, Jo Vandercappellen, Mieke Gouwy

Blood· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Paul Proost, Sofie Struyf, Tamara Loos, Mieke Gouwy, Evemie Schutyser

Arthritis Res Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.
Tamara Loos, Lies Dekeyzer, Sofie Struyf, Evemie Schutyser, Klara Gijsbers

Lab Invest· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Julie Catusse, Sofie Struyf, Anja Wuyts, Myke Weyler, Tamara Loos

Biochem Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis